FSD Pharma Completes Harvest and Passes Analytical Testing of Second Lot

Published: January 8, 2019

FSD Pharma Completes Harvest and Passes Analytical Testing of Second Lot

FSD Pharma Inc. announced that its wholly-owned subsidiary, FV Pharma Inc., a licensed cannabis producer under the Cannabis Act, has completed the harvest of its second lot of cannabis and successfully passed all analytical testing, thereby positioning the Company to request a Pre-Sales License Inspection from Health Canada. The Pre-Sales License Inspection is the last step prior to the issuance of a Sales License under the Cannabis Act and Regulations.

Zeeshan Saeed, President and Founder of FSD Pharma stated, “With the completion of analytical testing and the recent addition of grow rooms to our license, we are now positioned to submit our readiness report for a pre-sale inspection, while at the same time being able to continuously cultivate and harvest all existing licensed space so as to maximize supply to the medicinal and recreational markets. This is yet another significant step in the Company’s strategic implementation of its business plan to be the largest indoor licensed producer of cannabis.”